Page last updated: 2024-11-01

nisoldipine and Influenza, Human

nisoldipine has been researched along with Influenza, Human in 1 studies

Nisoldipine: A dihydropyridine calcium channel antagonist that acts as a potent arterial vasodilator and antihypertensive agent. It is also effective in patients with cardiac failure and angina.
nisoldipine : A racemate consisting of equimolar amounts of (R)- and (S)-nisoldipine. A calcium channel blocker, it is used in the treatment of hypertension and angina pectoris.
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a methoxycarbonyl group at position 3, an o-nitrophenyl group at position 4, and an isobutoxycarbonyl group at position 5. The racemate, a calcium channel blocker, is used in the treatment of hypertension and angina pectoris.

Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Huang, Y1
Li, Y1
Chen, Z1
Chen, L1
Liang, J1
Zhang, C1
Zhang, Z1
Yang, J1

Other Studies

1 other study available for nisoldipine and Influenza, Human

ArticleYear
Nisoldipine Inhibits Influenza A Virus Infection by Interfering with Virus Internalization Process.
    Viruses, 2022, 12-08, Volume: 14, Issue:12

    Topics: Antiviral Agents; COVID-19; Humans; Influenza A virus; Influenza, Human; Nisoldipine; SARS-CoV-2; Vi

2022